Invention Grant
- Patent Title: Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
-
Application No.: US11983987Application Date: 2007-11-13
-
Publication No.: US07632815B2Publication Date: 2009-12-15
- Inventor: Mark Anderson
- Applicant: Mark Anderson
- Applicant Address: US TN Nashville
- Assignee: Vanderbilt University
- Current Assignee: Vanderbilt University
- Current Assignee Address: US TN Nashville
- Agency: Ballard Spahr LLP
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The present invention provides a method for treating structural heart disease in a subject, comprising administering an effective amount of an inhibitor of CaMKII to the subject, whereby the administration of the inhibitor treats the structural heart disease in the subject. Also provided are transgenic animal models for treating structural heart disease. Further provided is a means of screening for a compound that can treat structural heart disease.
Public/Granted literature
- US20090011989A1 Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease Public/Granted day:2009-01-08
Information query
IPC分类:
